Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Hypertension (TAs > 130, TAd > 80mmHg or under antihypertensive treatment).
- Glomerular nephropathy, proteinuria > 1 g/day, serum creatinin < 200 µmol/L.
- Informed consent given.
- No contraindication for ARB and hydrochlorothiazide.
- Efficient contraception for women.